{"Title": "High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008", "Year": 2019, "Source": "J. Clin. Oncol.", "Volume": "37", "Issue": 34, "Art.No": null, "PageStart": 3192, "PageEnd": 3202, "CitedBy": 11, "DOI": "10.1200/JCO.19.00915", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075814144&origin=inward", "Abstract": "\u00a9 2019 by American Society of Clinical OncologyPURPOSE The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung irradiation (WLI) on event-free survival (main end point) and overall survival, compared with standard chemotherapy with WLI in Ewing sarcoma (ES) presenting with pulmonary and/or pleural metastases. METHODS From 2000 to 2015, we enrolled patients younger than 50 years of age with newly diagnosed ES and with only pulmonary or pleural metastases. Patients received chemotherapy with six courses of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) and one course of vincristine, dactinomycin, and ifosfamide (VAI) before either BuMel or seven courses of VAI and WLI (VAI plus WLI) by randomized assignment. The analysis was conducted as intention to treat. The estimates of the hazard ratio (HR), 95% CI, and P value were corrected for the three previous interim analyses by the inverse normal method. RESULTS Of 543 potentially eligible patients, 287 were randomly assigned to VAI plus WLI (n = 143) or BuMel (n = 144). Selected patients requiring radiotherapy to an axial primary site were excluded from randomization to avoid excess organ toxicity from interaction between radiotherapy and busulfan. Median follow-up was 8.1 years. We did not observe any significant difference in survival outcomes between treatment groups. Event-free survival was 50.6% versus 56.6% at 3 years and 43.1% versus 52.9% at 8 years, for VAI plus WLI and BuMel patients, respectively, resulting in an HR of 0.79 (95% CI, 0.56 to 1.10; P = .16). For overall survival, the HR was 1.00 (95% CI, 0.70 to 1.44; P = .99). Four patients died as a result of BuMel-related toxicity, and none died after VAI plus WLI. Significantly more patients in the BuMel arm experienced severe acute toxicities than in the VAI plus WLI arm. CONCLUSION In ES with pulmonary or pleural metastases, there is no clear benefit from BuMel compared with conventional VAI plus WLI.", "AuthorKeywords": null, "IndexKeywords": ["Adolescent", "Adult", "Antineoplastic Combined Chemotherapy Protocols", "Bone Neoplasms", "Child", "Child, Preschool", "Disease Progression", "Europe", "Female", "Hematopoietic Stem Cell Transplantation", "Humans", "Infant", "Lung Neoplasms", "Male", "Middle Aged", "Neoadjuvant Therapy", "Neoplasm Recurrence, Local", "Pneumonectomy", "Progression-Free Survival", "Radiotherapy, Adjuvant", "Risk Assessment", "Risk Factors", "Sarcoma, Ewing", "Time Factors", "Transplantation, Autologous", "Young Adult"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85075814144", "SubjectAreas": [["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"6603591929": {"Name": "Dirksen U.", "AuthorID": "6603591929", "AffiliationID": "60007896", "AffiliationName": "University Hospital Essen, Pediatrics III, West German Cancer Centre"}, "19033680000": {"Name": "Brennan B.", "AuthorID": "19033680000", "AffiliationID": "60023969", "AffiliationName": "Royal Manchester Children\u2019s Hospital"}, "6602476474": {"Name": "Le Deley M.C.", "AuthorID": "6602476474", "AffiliationID": "60106017", "AffiliationName": "Universit\u00e9 Paris-Saclay"}, "56084838600": {"Name": "Cozic N.", "AuthorID": "56084838600", "AffiliationID": "60106080", "AffiliationName": "Gustave Roussy"}, "6701858621": {"Name": "Gaspar N.", "AuthorID": "6701858621", "AffiliationID": "60106080", "AffiliationName": "Gustave Roussy"}, "7003991039": {"Name": "Oberlin O.", "AuthorID": "7003991039", "AffiliationID": "60106080", "AffiliationName": "Gustave Roussy"}, "7202434098": {"Name": "Van Den Berg H.", "AuthorID": "7202434098", "AffiliationID": "60002483, 60070178", "AffiliationName": "Emma Children Hospital, Amsterdam University Medical Centres"}, "26649812700": {"Name": "Bhadri V.", "AuthorID": "26649812700", "AffiliationID": "122142580", "AffiliationName": "Chris O\u2019Brien Lifehouse"}, "7007112159": {"Name": "Brichard B.", "AuthorID": "7007112159", "AffiliationID": "60012936", "AffiliationName": "Cliniques Universitaires Saint Luc"}, "6603216006": {"Name": "Claude L.", "AuthorID": "6603216006", "AffiliationID": "60018084", "AffiliationName": "Centre L\u00e9on B\u00e9rard"}, "7103269761": {"Name": "Craft A.", "AuthorID": "7103269761", "AffiliationID": "60026712", "AffiliationName": "Northern Institute for Cancer Research"}, "25951330100": {"Name": "Amler S.", "AuthorID": "25951330100", "AffiliationID": "60072320", "AffiliationName": "Friedrich-Loeffler Institute"}, "8735653600": {"Name": "Gelderblom H.", "AuthorID": "8735653600", "AffiliationID": "60015618", "AffiliationName": "Leiden University Medical Center"}, "7006226606": {"Name": "Goldsby R.", "AuthorID": "7006226606", "AffiliationID": "60033399", "AffiliationName": "University of California San Francisco Benioff Children\u2019s Hospital"}, "7003393650": {"Name": "Gorlick R.", "AuthorID": "7003393650", "AffiliationID": "60015023", "AffiliationName": "MD Anderson Cancer Center"}, "35392726800": {"Name": "Grier H.E.", "AuthorID": "35392726800", "AffiliationID": "60014334", "AffiliationName": "Dana-Farber/Boston Children\u2019s Cancer and Blood Disorder Center"}, "22634206400": {"Name": "Janeway K.", "AuthorID": "22634206400", "AffiliationID": "60014334", "AffiliationName": "Dana-Farber/Boston Children\u2019s Cancer and Blood Disorder Center"}, "57212059438": {"Name": "Guinbretiere J.M.", "AuthorID": "57212059438", "AffiliationID": "112659597", "AffiliationName": "H\u00f4pital Ren\u00e9-Huguenin"}, "35721962700": {"Name": "Hauser P.", "AuthorID": "35721962700", "AffiliationID": "60024812", "AffiliationName": "Semmelweis University"}, "7003265353": {"Name": "Hjorth L.", "AuthorID": "7003265353", "AffiliationID": "60029170", "AffiliationName": "Lund University"}, "13611936100": {"Name": "Juergens H.", "AuthorID": "13611936100", "AffiliationID": "123699984", "AffiliationName": "Universitaetskinderklinik Muenster"}, "34975076700": {"Name": "Judson I.", "AuthorID": "34975076700", "AffiliationID": "60017166", "AffiliationName": "Royal Marsden Foundation NHS Trust"}, "7005294008": {"Name": "Krailo M.", "AuthorID": "7005294008", "AffiliationID": "60029311", "AffiliationName": "University of Southern California"}, "15765627700": {"Name": "Kruseova J.", "AuthorID": "15765627700", "AffiliationID": "60016605", "AffiliationName": "Charles University"}, "56557978900": {"Name": "Kuehne T.", "AuthorID": "56557978900", "AffiliationID": "60006655", "AffiliationName": "University Children\u2019s Hospital Basel"}, "7006309750": {"Name": "Ladenstein R.", "AuthorID": "7006309750", "AffiliationID": "60011394", "AffiliationName": "Medical University of Vienna"}, "8675032700": {"Name": "Lervat C.", "AuthorID": "8675032700", "AffiliationID": "60013858", "AffiliationName": "Centre Oscar Lambret"}, "6602249150": {"Name": "Lessnick S.L.", "AuthorID": "6602249150", "AffiliationID": "60032497, 60080012", "AffiliationName": "Nationwide Children\u2019s Hospital, Ohio State University College of Medicine"}, "21534699100": {"Name": "Lewis I.", "AuthorID": "21534699100", "AffiliationID": "60012070", "AffiliationName": "University of Leeds"}, "7004549206": {"Name": "Linassier C.", "AuthorID": "7004549206", "AffiliationID": "60016638", "AffiliationName": "Centre Hospitalier Universitaire"}, "6602989646": {"Name": "Marec-Berard P.", "AuthorID": "6602989646", "AffiliationID": "121521701", "AffiliationName": "Institute of Pediatric Onco-Haematology"}, "8064101600": {"Name": "Marina N.", "AuthorID": "8064101600", "AffiliationID": "123554292", "AffiliationName": "Five Time Therapeutics"}, "57202953721": {"Name": "Morland B.", "AuthorID": "57202953721", "AffiliationID": "60022357, 60015857", "AffiliationName": "Birmingham Women and Children\u2019s Hospital"}, "6603870485": {"Name": "Pacquement H.", "AuthorID": "6603870485", "AffiliationID": "60030640", "AffiliationName": "Institut Curie"}, "6604088461": {"Name": "Paulussen M.", "AuthorID": "6604088461", "AffiliationID": "60022113", "AffiliationName": "Witten/Herdecke University"}, "7201628512": {"Name": "Randall R.L.", "AuthorID": "7201628512", "AffiliationID": "60014439", "AffiliationName": "University of California Davis"}, "22942006800": {"Name": "Ranft A.", "AuthorID": "22942006800", "AffiliationID": "60106017, 60106080", "AffiliationName": "Gustave Roussy, Universit\u00e9 Paris-Saclay"}, "11640458900": {"Name": "Le Teuff G.", "AuthorID": "11640458900", "AffiliationID": "60019702", "AffiliationName": "University of Birmingham"}, "55620170800": {"Name": "Wheatley K.", "AuthorID": "55620170800", "AffiliationID": "60027403", "AffiliationName": "University College Hospital"}, "7202609757": {"Name": "Whelan J.", "AuthorID": "7202609757", "AffiliationID": "60006297, 60030118", "AffiliationName": "Children\u2019s Hospital of Philadelphia, University of Pennsylvania"}, "7003580850": {"Name": "Womer R.", "AuthorID": "7003580850", "AffiliationID": "60138686", "AffiliationName": "Seattle Children\u2019s Hospital"}, "7202029617": {"Name": "Hawkins D.S.", "AuthorID": "7202029617", "AffiliationID": "60138686", "AffiliationName": "Seattle Children\u2019s Hospital"}}}